Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2010
04/28/2010CN1860228B Staple type oligonucleotide and drug comprising the same
04/28/2010CN1857293B Medicine composition containing wild astragaloside and paeoniforin
04/28/2010CN1856305B Pyridine derivatives as urotensin II antagonists
04/28/2010CN1845749B Use of a single-cell protein material
04/28/2010CN1845748B Pharmaceutical use of fish protein hydrolyzate
04/28/2010CN1843368B Breviscapinum long-circulating nanoliposome and its preparation method
04/28/2010CN1817354B Injection of manchurian wildginge and astragalus root and its preparing method
04/28/2010CN1785253B Micro-balls of compound red-rooted salvia injection, and its preparation method
04/28/2010CN1778322B Chinese medicine for treating cardiovascular disease
04/28/2010CN1777419B Pharmaceutical compositions of CETP inhibitors
04/28/2010CN1772008B Process of preparing ginkgo-dipyridamole for injection and its quality control method
04/28/2010CN1758913B Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
04/28/2010CN1709286B Lyophilized powder injection for treating ischemic cardio-cerebrovascular diseases and its preparing method
04/28/2010CN1698717B Chinese medicinal compound fat emulsion injection and its preparation method
04/28/2010CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
04/28/2010CN1615971B Injection emulsion for refreshment and its preparing method
04/28/2010CN1596266B Specific binding agents of human angiopoietin-2
04/28/2010CN1582946B Use of centellosic acid derivative in preparation of medicines for diseases of cardio-cerebral blood vessels
04/28/2010CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine,
04/28/2010CN1556705B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
04/28/2010CN1555417B Paramyxovirus vector for gene transfer to the cardiovascular system
04/28/2010CN1548039B Red sage dripping pill and its preparation
04/28/2010CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases
04/28/2010CN1468307B Anti-dual integrin antibodies, compositions, methods and uses
04/28/2010CN1444948B Liposome of Breviscapine and its preparing method
04/28/2010CN101698816A Coix seed wine and coix seed ginseng root wine
04/28/2010CN101698093A Drug composition oral preparation used for relaxing tendons and activating collaterals and preparation method thereof
04/28/2010CN101698090A Traditional Chinese medicine composite for treating coma and heart syncope symptoms and preparation method thereof
04/28/2010CN101698086A Medicine for treating vasculitis and preparation method thereof
04/28/2010CN101698082A Traditional Chinese medicine composite for treating high blood pressure
04/28/2010CN101698081A Traditional Chinese medicine composition used for treating hypertension and preparation method thereof
04/28/2010CN101698069A Traditional Chinese medicine preparation for treating cervical vertigo
04/28/2010CN101698065A Medicament for treating haemorrhoids
04/28/2010CN101698052A Application of traditional Chinese medicine composite in preparing medicine treating acute myocardial infarction associated with arrhythmia
04/28/2010CN101698051A Application of traditional Chinese medicine composite in preparing medicine treating climacteric syndrome
04/28/2010CN101698050A Application of traditional Chinese medicine composite in preparing medicine treating paroxysmal atrial fibrillation
04/28/2010CN101698049A Application of traditional Chinese medicine composite in preparing medicine treating organic cardiopathy type arrhythmia
04/28/2010CN101698048A Traditional Chinese medicine ointment for treating high blood pressure and preparation method thereof
04/28/2010CN101698036A Traditional Chinese medicine for treating haemorrhoids, traditional Chinese medicine cataplasm and preparation method thereof
04/28/2010CN101698031A Method for separating short-tube lycoris total alkaloids by ion exchange resin
04/28/2010CN101697990A Application of notoginseng and extract thereof in preparing medicaments for treating and/or preventing restenosis after PTCA
04/28/2010CN101697989A Application of notoginseng and extract thereof in preparing medicaments for treating and/or preventing coronary artherosclerosis
04/28/2010CN101697988A Taste hiding composition and application thereof in Xuesaitong chewable tablet
04/28/2010CN101697979A Officinal fungus mycelium extract and preparation method thereof
04/28/2010CN101697977A Deproteinized calf blood extractive injection and preparation method thereof
04/28/2010CN101697970A Medicine composite for treating and relieving high blood pressure
04/28/2010CN101229160B Antihypertensive medicine containing amlodipine besylate
04/27/2010USRE41288 increasing insulinotropic response in ischemia and treating reperfusion and injured brain cells after an ischemic event by administering glucagon-like peptide-1 and a pharmaceutical carrier for a time sufficient and under conditions effective to increase insulinotropic response which produces insulin
04/27/2010USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors
04/27/2010US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
04/27/2010US7705043 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases
04/27/2010US7705020 Benzimidazolone carboxylic acid derivatives
04/27/2010US7705015 Substituted pyrroline kinase inhibitors
04/27/2010US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
04/27/2010US7704988 N-[3-(4-{(2S,3R)-2-(-(4-{[(2S, 5S, 3R, 4R, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)perhydro-2H-pyran-2-yl]ethyl-2-yl}phenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phenyl)propyl]-N-methylmethanesulfonamide; anticholesterol agent; low density lipoprotein; treating atherosclerosis
04/27/2010US7704975 Modafinil compound and cyclodextrin mixtures
04/27/2010US7704969 Transfection complexes
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704947 Methods and compositions for the treatment of gastrointestinal disorders
04/27/2010US7704526 Sustained release composition for oral administration of drugs
04/27/2010US7704523 Microbial cellulose wound dressing for treating chronic wounds
04/27/2010US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1
04/27/2010CA2486571C Pharmaceutical composition
04/27/2010CA2462939C Novel derivatives of isoquinoline, process for their preparation and pharmaceutical compositions containing them
04/27/2010CA2431645C Methods of treating hormonal deficiencies in women undergoing estrogen replacement therapy
04/27/2010CA2427482C Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/27/2010CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/27/2010CA2323776C Cytokine receptor common gamma chain like
04/27/2010CA2321951C Dietary control of arachidonic acid metabolism
04/27/2010CA2321926C Use of rhamnolipids in a composition for the treatment of signs of aging
04/27/2010CA2278465C Diagnosis and treatment of myocardial failure
04/22/2010WO2010045582A2 Compositions and methods for treating or preventing hypoxic or ischemic injury
04/22/2010WO2010045575A2 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
04/22/2010WO2010045509A2 Modulation of factor 11 expression
04/22/2010WO2010045371A1 Pyrido- and pyrimido (1, 2-a) pyrimidine compounds useful as stearoyl coa desaturase inhibitors
04/22/2010WO2010045190A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors
04/22/2010WO2010045166A1 Heterocyclic benzimidazoles as trpm8 modulators
04/22/2010WO2010044441A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase
04/22/2010WO2010044094A2 A topical composition for the treatment of erectile dysfunction
04/22/2010WO2010044070A2 Synergistic composition for recovery and reduction of mild ischemic damage
04/22/2010WO2010043976A2 Highly pure ranolazine or a pharmaceutically acceptable salt thereof
04/22/2010WO2010043972A2 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury
04/22/2010WO2010043950A2 Propafenone extended release composition
04/22/2010WO2010043444A2 Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof
04/22/2010WO2010043156A1 Drop pill for treating coronary heart disease and preparation thereof
04/22/2010WO2010043109A1 The use of corynantheine in preparation of medicaments for treating myocardial damage heart disease
04/22/2010WO2010043076A1 A method for constructing human placental mesenchymal cells library which is suitable for clinical application
04/22/2010WO2010043045A1 Annexin and its use to treat inflammatory disorders
04/22/2010WO2010043010A1 N-acyl hydrazine derivatives, method for producing n-acyl hydrazine compounds, pharmaceutical compositions containing same, uses thereof and methods for treatment
04/22/2010WO2010043000A1 S1p receptors modulators and their use thereof
04/22/2010WO2010011319A8 Magnetic heating for drug delivery and other applications
04/22/2010WO2010009120A3 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
04/22/2010WO2010002583A3 Natriuretic polypeptides with unique pharmacologic profiles
04/22/2010WO2009158309A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
04/22/2010WO2009151770A3 Colchicine solid-state forms; methods of making; and methods of use thereof
04/22/2010WO2009143363A3 Functional metabolomics coupled microfluidic chemotaxis device and identification of novel cell mediators
04/22/2010WO2009043450A8 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents
04/22/2010WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof
04/22/2010US20100099729 Nitric oxide donor compounds
1 ... 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 ... 1595